Gary Nachman
Stock Analyst at Canaccord Genuity
(2.65)
# 2,965
Out of 4,707 analysts
496
Total ratings
46.6%
Success rate
1.1%
Average return
Main Sectors:
Stocks Rated by Gary Nachman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IONS Ionis Pharmaceuticals | Maintained: Buy | $95 → $85 | $56.71 | +49.89% | 38 | Sep 8, 2026 | |
| JAZZ Jazz Pharmaceuticals | Maintained: Buy | $300 | $240.07 | +24.96% | 53 | Aug 31, 2026 | |
| ACHV Achieve Life Sciences | Reiterated: Buy | $13 | $7.84 | +65.82% | 9 | Aug 12, 2026 | |
| SRRK Scholar Rock Holding | Reiterated: Buy | $62 | $57.42 | +7.98% | 15 | Aug 12, 2026 | |
| ANIP ANI Pharmaceuticals | Maintained: Hold | $91 → $90 | $70.23 | +28.15% | 6 | Aug 10, 2026 | |
| ADMA ADMA Biologics | Maintained: Buy | $18 | $9.54 | +88.68% | 9 | Aug 6, 2026 | |
| AMGN Amgen | Maintained: Hold | $366 → $384 | $393.17 | -2.33% | 5 | Aug 5, 2026 | |
| ABBV AbbVie | Reiterated: Buy | $282 → $290 | $248.78 | +16.57% | 45 | Aug 3, 2026 | |
| ETON Eton Pharmaceuticals | Reiterated: Buy | $60 | $59.35 | +1.10% | 2 | Jul 30, 2026 | |
| PCRX Pacira BioSciences | Maintained: Hold | n/a | $25.87 | - | 48 | Oct 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16.56 | $11.39 | +45.46% | 7 | Oct 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3 → $20 | $2.58 | n/a | 2 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $2.51 | n/a | 5 | Aug 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $37 → $40 | $5.33 | n/a | 2 | Jul 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7 | $5.21 | n/a | 18 | Jun 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $19 → $22 | $17.73 | n/a | 2 | Feb 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $298 | $260.10 | n/a | 23 | Jan 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7 → $4 | $69.37 | n/a | 7 | Aug 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $200 → $100 | $0.0001 | n/a | 8 | Mar 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 → $4 | $9.60 | n/a | 22 | Mar 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $4 | $17.05 | n/a | 19 | Mar 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $35 → $30 | $9.43 | n/a | 7 | Mar 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $83 → $78 | $20.03 | n/a | 5 | Mar 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $14 | $16.61 | n/a | 17 | Feb 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $11.04 → $13.80 | $8.86 | n/a | 42 | Feb 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $40 → $32 | $11.44 | n/a | 11 | Feb 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $10 | $36.76 | n/a | 7 | Feb 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $3 | $47.37 | n/a | 11 | Jan 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $60 → $35 | $0.0001 | n/a | 10 | Nov 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $27 → $25 | $5.33 | n/a | 6 | Aug 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $180 | $1.41 | n/a | 3 | Aug 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $13 → $12 | $16.82 | n/a | 5 | May 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $21 | $22.93 | n/a | 14 | May 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 → $3 | $0.0001 | n/a | 5 | Sep 5, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $80 | $55.04 | n/a | 1 | Sep 14, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $138 | $94.22 | n/a | 3 | Apr 27, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $9.5 → $14 | $4.17 | n/a | 2 | Mar 21, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $6.8 | $14.25 | n/a | 2 | Oct 9, 2013 |
Ionis Pharmaceuticals
Sep 8, 2026
Maintained: Buy
Price Target: $95 → $85
Current: $56.71
Upside: +49.89%
Jazz Pharmaceuticals
Aug 31, 2026
Maintained: Buy
Price Target: $300
Current: $240.07
Upside: +24.96%
Achieve Life Sciences
Aug 12, 2026
Reiterated: Buy
Price Target: $13
Current: $7.84
Upside: +65.82%
Scholar Rock Holding
Aug 12, 2026
Reiterated: Buy
Price Target: $62
Current: $57.42
Upside: +7.98%
ANI Pharmaceuticals
Aug 10, 2026
Maintained: Hold
Price Target: $91 → $90
Current: $70.23
Upside: +28.15%
ADMA Biologics
Aug 6, 2026
Maintained: Buy
Price Target: $18
Current: $9.54
Upside: +88.68%
Amgen
Aug 5, 2026
Maintained: Hold
Price Target: $366 → $384
Current: $393.17
Upside: -2.33%
AbbVie
Aug 3, 2026
Reiterated: Buy
Price Target: $282 → $290
Current: $248.78
Upside: +16.57%
Eton Pharmaceuticals
Jul 30, 2026
Reiterated: Buy
Price Target: $60
Current: $59.35
Upside: +1.10%
Pacira BioSciences
Oct 6, 2025
Maintained: Hold
Price Target: n/a
Current: $25.87
Upside: -
Oct 2, 2025
Maintained: Buy
Price Target: $16.56
Current: $11.39
Upside: +45.46%
Aug 13, 2025
Maintained: Buy
Price Target: $3 → $20
Current: $2.58
Upside: n/a
Aug 4, 2025
Reiterated: Hold
Price Target: n/a
Current: $2.51
Upside: n/a
Jul 31, 2025
Maintained: Buy
Price Target: $37 → $40
Current: $5.33
Upside: n/a
Jun 17, 2025
Maintained: Buy
Price Target: $7
Current: $5.21
Upside: n/a
Feb 20, 2025
Maintained: Buy
Price Target: $19 → $22
Current: $17.73
Upside: n/a
Jan 15, 2025
Reiterated: Buy
Price Target: $298
Current: $260.10
Upside: n/a
Aug 19, 2024
Maintained: Buy
Price Target: $7 → $4
Current: $69.37
Upside: n/a
Mar 16, 2023
Rated: Buy
Price Target: $200 → $100
Current: $0.0001
Upside: n/a
Mar 8, 2023
Maintained: Buy
Price Target: $5 → $4
Current: $9.60
Upside: n/a
Mar 2, 2023
Rated: Hold
Price Target: $4
Current: $17.05
Upside: n/a
Mar 1, 2023
Maintained: Buy
Price Target: $35 → $30
Current: $9.43
Upside: n/a
Mar 1, 2023
Maintained: Buy
Price Target: $83 → $78
Current: $20.03
Upside: n/a
Feb 27, 2023
Rated: Hold
Price Target: $14
Current: $16.61
Upside: n/a
Feb 24, 2023
Maintained: Hold
Price Target: $11.04 → $13.80
Current: $8.86
Upside: n/a
Feb 22, 2023
Rated: Buy
Price Target: $40 → $32
Current: $11.44
Upside: n/a
Feb 8, 2023
Rated: Hold
Price Target: $10
Current: $36.76
Upside: n/a
Jan 9, 2023
Rated: Buy
Price Target: $3
Current: $47.37
Upside: n/a
Nov 10, 2022
Maintained: Buy
Price Target: $60 → $35
Current: $0.0001
Upside: n/a
Aug 11, 2022
Reiterated: Buy
Price Target: $27 → $25
Current: $5.33
Upside: n/a
Aug 2, 2021
Maintained: Buy
Price Target: $180
Current: $1.41
Upside: n/a
May 14, 2021
Rated: Buy
Price Target: $13 → $12
Current: $16.82
Upside: n/a
May 11, 2020
Maintained: Hold
Price Target: $21
Current: $22.93
Upside: n/a
Sep 5, 2019
Maintained: Buy
Price Target: $9 → $3
Current: $0.0001
Upside: n/a
Sep 14, 2017
Maintained: Buy
Price Target: $80
Current: $55.04
Upside: n/a
Apr 27, 2017
Reiterated: Buy
Price Target: $138
Current: $94.22
Upside: n/a
Mar 21, 2016
Initiated Coverage: Hold
Price Target: $9.5 → $14
Current: $4.17
Upside: n/a
Oct 9, 2013
Maintained: Hold
Price Target: $6.8
Current: $14.25
Upside: n/a